DivGro is now DivGro 2.0!

DivGro moved to another platform and is now DivGro 2.0!

Please enjoy complimentary access to all the content on DivGro 2.0 until I formally launch it! You can sign up for free and join more than 1,090 existing members!

All content will be complimentary until the formal launch of DivGro 2.0. This includes my monthly newsletter and articles like
 How to Assess Dividend Quality and The Chowder Ruleand a live spreadsheet of my DivGro Portfolio.

Read more About DivGro 2.0 ...

Saturday, April 8, 2017

I'm Adding CVS Health To My DivGro Portfolio


CVS Health Corporation (CVS) ranked third in the March edition of my 10 Dividend Growth Stocks series of articles on Seeking Alpha.

The stock is trading down more than 30% from an all-time high price of $113.45, recorded in July 2015. As a result, CVS is trading at a 5-year high yield.

In this article, I explain why I'm adding CVS to DivGro. The article provides a full stock analysis and includes some risk factors, too.

About CVS Health

Founded in 1892 and headquartered in Woonsocket, Rhode Island, CVS provides integrated pharmacy health care services. The company offers a range of products and services, including advising patients on their medications at CVS Pharmacy locations; providing cost control programs through CVS Caremark; delivering care to patients with conditions through CVS Specialty; and pharmacy care for the senior community through Omnicare.

CVS is a Dividend Contender with a track record of 14 consecutive years of dividend increases and an impressive 10-year dividend growth rate of 27%. The stock pays quarterly dividends of 50¢ per share in the months of February, May, August, and November.

To see my stock analysis and to learn why I added CVS to DivGro, please read this article at Seeking Alpha.

Feel free to comment on this article either here or at Seeking Alpha.

2 comments :

  1. Hi Ferdi , retail is tough business , CVS 's net profit margin at 3% is even lower then WMT's . What is your point ?

    ReplyDelete
    Replies
    1. I guess I'm not quite sure how to respond to your question. Did you read the article at Seeking Alpha? If it doesn't provide the case for a long-term investment in CVS for the DGI, I guess I can't convince you. Take care.

      Delete

Please don't include links in comments. I will mark such comments as spam and the comment won't be published. To make me aware of your blog or website, comment on my Blogrole page instead.

Subscribe to Portfolio Insight and Save!

Use my affiliate link to sign up for a free 14-day, no-obligation trial of Portfolio Insight. No credit card required. If you decide to subscribe during the trial period, you'll receive a 20% discount on the first year's annual subscription price of $330. Please note the 20% affiliate discount does not apply to the monthly rate.